Rare diseases
Investigational molecules
Locations
Medical Center Boulevard, 27157-0001, United States
Wake Forest University Health Sciences is involved in clinical research focused on amnestic mild cognitive impairment and early-stage Alzheimer's disease, with attention to conditions marked by early cognitive decline and biomarker-defined disease activity.
The sponsor's research activity in this area centers on identifying therapeutic strategies relevant to the transition from mild impairment to more advanced neurodegenerative disease.
Wake Forest University Health Sciences runs clinical trials in conditions such as Dementia Alzheimer's type, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
